Skip to main content
Erschienen in: The Patient - Patient-Centered Outcomes Research 5/2016

01.10.2016 | Commentary

Instrument Development in Choice Experiments. Commentary on: “Applying a Framework for Instrument Development of a Choice Experiment to Measure Treatment Preferences in Type 2 Diabetes”

verfasst von: Eve Wittenberg

Erschienen in: The Patient - Patient-Centered Outcomes Research | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Excerpt

Patients are the ultimate source of what they want, desire, and value. To truly understand patients and their preferences, we need to go directly to them. Asking patients what they prefer is superior to observing what they actually choose (in economic parlance, revealed choices) because actual choices are constrained by the range of options available. Hence asking patients what they want, although hypothetical by definition, can provide information about their values free from the constraints of actual choice. …
Literatur
1.
Zurück zum Zitat Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32:883–902.CrossRefPubMed Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32:883–902.CrossRefPubMed
2.
Zurück zum Zitat Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health: a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403–13.CrossRefPubMed Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health: a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403–13.CrossRefPubMed
3.
Zurück zum Zitat Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16:3–13.CrossRefPubMed Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16:3–13.CrossRefPubMed
4.
Zurück zum Zitat Hauber A, Gonzalez J, Groothius-Oudshoorn C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300-15.CrossRefPubMed Hauber A, Gonzalez J, Groothius-Oudshoorn C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300-15.CrossRefPubMed
5.
Zurück zum Zitat Coast J, Flynn TN, Natarajan L, et al. Valuing the ICECAP capability index for older people. Soc Sci Med. 2008;67:874–82.CrossRefPubMed Coast J, Flynn TN, Natarajan L, et al. Valuing the ICECAP capability index for older people. Soc Sci Med. 2008;67:874–82.CrossRefPubMed
6.
Zurück zum Zitat dosReis S, Ng X, Frosch E, Reeves G, Cunningham C, Bridges JF. Using best-worst scaling to measure caregiver preferences for managing their child’s ADHD: a pilot study. Patient. 2015;8:423–31.CrossRefPubMed dosReis S, Ng X, Frosch E, Reeves G, Cunningham C, Bridges JF. Using best-worst scaling to measure caregiver preferences for managing their child’s ADHD: a pilot study. Patient. 2015;8:423–31.CrossRefPubMed
7.
Zurück zum Zitat Peay HL, Hollin I, Fischer R, Bridges JF. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Clin Ther. 2014;36:624–37.CrossRefPubMed Peay HL, Hollin I, Fischer R, Bridges JF. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Clin Ther. 2014;36:624–37.CrossRefPubMed
8.
Zurück zum Zitat Ross M, Bridges JF, Ng X, et al. A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children. Psychiatr Serv. 2015;66:208–11.CrossRefPubMed Ross M, Bridges JF, Ng X, et al. A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children. Psychiatr Serv. 2015;66:208–11.CrossRefPubMed
9.
Zurück zum Zitat Wittenberg E, Bharel M, Saada A, Santiago E, Bridges JF, Weinreb L. Measuring the preferences of homeless women for cervical cancer screening interventions: development of a best-worst scaling survey. Patient. 2015;8:455–67.CrossRefPubMed Wittenberg E, Bharel M, Saada A, Santiago E, Bridges JF, Weinreb L. Measuring the preferences of homeless women for cervical cancer screening interventions: development of a best-worst scaling survey. Patient. 2015;8:455–67.CrossRefPubMed
10.
Zurück zum Zitat O’Hara NN, Roy L, O’Hara LM, et al. Healthcare worker preferences for active tuberculosis case finding programs in South Africa: a best-worst scaling choice experiment. PLoS One. 2015;10:e0133304.CrossRefPubMedPubMedCentral O’Hara NN, Roy L, O’Hara LM, et al. Healthcare worker preferences for active tuberculosis case finding programs in South Africa: a best-worst scaling choice experiment. PLoS One. 2015;10:e0133304.CrossRefPubMedPubMedCentral
11.
12.
Zurück zum Zitat Coast J, Al-Janabi H, Sutton EJ, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21:730–41.CrossRefPubMed Coast J, Al-Janabi H, Sutton EJ, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21:730–41.CrossRefPubMed
13.
Zurück zum Zitat Flynn TN, Louviere JJ, Marley AA, Coast J, Peters TJ. Rescaling quality of life values from discrete choice experiments for use as QALYs: a cautionary tale. Popul Health Metr. 2008;6:6.CrossRefPubMedPubMedCentral Flynn TN, Louviere JJ, Marley AA, Coast J, Peters TJ. Rescaling quality of life values from discrete choice experiments for use as QALYs: a cautionary tale. Popul Health Metr. 2008;6:6.CrossRefPubMedPubMedCentral
Metadaten
Titel
Instrument Development in Choice Experiments. Commentary on: “Applying a Framework for Instrument Development of a Choice Experiment to Measure Treatment Preferences in Type 2 Diabetes”
verfasst von
Eve Wittenberg
Publikationsdatum
01.10.2016
Verlag
Springer International Publishing
Erschienen in
The Patient - Patient-Centered Outcomes Research / Ausgabe 5/2016
Print ISSN: 1178-1653
Elektronische ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-016-0186-8

Weitere Artikel der Ausgabe 5/2016

The Patient - Patient-Centered Outcomes Research 5/2016 Zur Ausgabe